N-DEAOP-NMT

N-DEAOP-NMT
Clinical data
Other names	N-(3-Diethylamino-3-oxopropyl)-NMT; N-DEAOP-NMT; N-(2-Diethylcarbamoylethyl)-N-methyltryptamine; N-DECE-NMT; NMT-N-(CH2-CH2-CONEt2)
Drug class	Simplified/partial LSD analogue
Chemical and physical data
Formula	C18H27N3O
Molar mass	301.434 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCN(CC)C(=O)CCN(C)CCc1c[nH]c2ccccc12;
	InChI InChI=1S/C18H27N3O/c1-4-21(5-2)18(22)11-13-20(3)12-10-15-14-19-17-9-7-6-8-16(15)17/h6-9,14,19H,4-5,10-13H2,1-3H3; Key:KRNAXWYCPYUSGZ-UHFFFAOYSA-N;

N-(3-Diethylamino-3-oxopropyl)-N-methyltryptamine (N-DEAOP-NMT) is a tryptamine derivative and a "partial" or simplified ergoline which is closely related to the highly potent serotonergic psychedelic lysergic acid diethylamide (LSD). It is the analogue of LSD in which two of LSD's carbon atoms in the ergoline ring, those at positions 9 and 10, have been removed. This in turn renders the N-DEAOP-NMT molecule flexible and makes it a non-rigid tryptamine rather than an ergoline. The compound is pharmacologically active, as are a number of its analogues and derivatives, with activities of the compounds including serotonin 5-HT_2A receptor agonism and LSD- or hallucinogen-like effects.